company background image
4527 logo

Rohto PharmaceuticalLtd TSE:4527 Stock Report

Last Price

JP¥2.89k

Market Cap

JP¥658.2b

7D

-2.8%

1Y

5.1%

Updated

06 Apr, 2024

Data

Company Financials +

Rohto Pharmaceutical Co.,Ltd.

TSE:4527 Stock Report

Market Cap: JP¥658.2b

4527 Stock Overview

Rohto Pharmaceutical Co.,Ltd. produziert und vertreibt weltweit pharmazeutische Produkte, Kosmetika und funktionelle Lebensmittel.

4527 fundamental analysis
Snowflake Score
Valuation6/6
Future Growth3/6
Past Performance4/6
Financial Health6/6
Dividends0/6

Rohto Pharmaceutical Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Rohto PharmaceuticalLtd
Historical stock prices
Current Share PriceJP¥2,885.00
52 Week HighJP¥4,117.00
52 Week LowJP¥2,666.50
Beta-0.080
1 Month Change-3.27%
3 Month Change-1.22%
1 Year Change5.06%
3 Year Change98.62%
5 Year Change96.13%
Change since IPO1,252.87%

Recent News & Updates

These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Safely

Apr 03
These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Safely

Here's Why We Think Rohto PharmaceuticalLtd (TSE:4527) Is Well Worth Watching

Mar 21
Here's Why We Think Rohto PharmaceuticalLtd (TSE:4527) Is Well Worth Watching

Recent updates

These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Safely

Apr 03
These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Safely

Here's Why We Think Rohto PharmaceuticalLtd (TSE:4527) Is Well Worth Watching

Mar 21
Here's Why We Think Rohto PharmaceuticalLtd (TSE:4527) Is Well Worth Watching

Rohto PharmaceuticalLtd (TSE:4527) Is Paying Out A Larger Dividend Than Last Year

Mar 07
Rohto PharmaceuticalLtd (TSE:4527) Is Paying Out A Larger Dividend Than Last Year

Estimating The Intrinsic Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)

Feb 26
Estimating The Intrinsic Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)

Shareholder Returns

4527JP Personal ProductsJP Market
7D-2.8%2.6%-2.5%
1Y5.1%-13.8%34.7%

Rendite im Vergleich zur Industrie: 4527 übertraf die Branche JP Personal Products , die im vergangenen Jahr eine Rendite von -15 erzielte.

Rendite vs. Markt: 4527 hinter dem Markt JP zurück, der im vergangenen Jahr eine Rendite von 27.5 erzielte.

Price Volatility

Is 4527's price volatile compared to industry and market?
4527 volatility
4527 Average Weekly Movement4.7%
Personal Products Industry Average Movement4.0%
Market Average Movement4.0%
10% most volatile stocks in JP Market8.3%
10% least volatile stocks in JP Market2.2%

Stabiler Aktienkurs: 4527 hatte in den letzten 3 Monaten keine nennenswerte Preisvolatilität.

Volatilität im Zeitverlauf: 4527Die wöchentliche Volatilität (4%) ist im vergangenen Jahr stabil geblieben.

About the Company

FoundedEmployeesCEOWebsite
18997,176Yamada Kuniohttps://www.rohto.co.jp

Rohto Pharmaceutical Co.,Ltd. produziert und vertreibt weltweit pharmazeutische Produkte, Kosmetika und funktionelle Lebensmittel. Das Unternehmen bietet Augenpflegeprodukte wie Augentropfen, Pflegemittel für Kontaktlinsen und Augenspülungen sowie Gesichtspflegeprodukte wie Gesichtswasser, Lotionen und Cremes an.

Rohto Pharmaceutical Co.,Ltd. Fundamentals Summary

How do Rohto PharmaceuticalLtd's earnings and revenue compare to its market cap?
4527 fundamental statistics
Market capJP¥658.18b
Earnings (TTM)JP¥30.90b
Revenue (TTM)JP¥263.56b

21.3x

P/E Ratio

2.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4527 income statement (TTM)
RevenueJP¥263.56b
Cost of RevenueJP¥110.16b
Gross ProfitJP¥153.41b
Other ExpensesJP¥122.51b
EarningsJP¥30.90b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)135.43
Gross Margin58.20%
Net Profit Margin11.72%
Debt/Equity Ratio3.9%

How did 4527 perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

10%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.